Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UNC5293, a potent, orally available and highly MERTK-selective inhibitor
Hongchao Zheng, Jichen Zhao, Bing Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113534-113534
Closed Access | Times Cited: 11

Showing 11 citing articles:

Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
Deyu Kong, Qiang Tian, Zhilong Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5866-5882
Closed Access | Times Cited: 5
Exploiting Structural Variability in the Kinase Back-Pocket to Modulate Polypharmacology of Tam Inhibitors
Megan D. Hopkins, Dehui� Zhang, Zhilong Chen, et al.
(2025)
Closed Access
Discovery of Novel TYRO3/MERTK Dual Inhibitors
Deyu Kong, Jichen Zhao, Daowei Huang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma
Le Yu, Yu Deng, Xiaodong Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitors
Megan D. Hopkins, Dehui� Zhang, Zhilong Chen, et al.
European Journal of Medicinal Chemistry (2025), pp. 117561-117561
Closed Access
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Yi‐Yun Yu, Miyeon Jang, Julie M. Miyashiro, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17000-17032
Closed Access | Times Cited: 2
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment
Mu‐Chun Li, You-Liang Lai, Po-Hsien Kuo, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10906-10927
Open Access | Times Cited: 1
Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review)
Zhen Tan, Jie Deng, Qianwei Ye, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 10, pp. 2645-2662
Closed Access | Times Cited: 2
Structure and functions of Mer, an innate immune checkpoint
Eric Ubil, Kashif Rafiq Zahid
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents
Li Wang, Yubai Zhou, Xuedan Wu, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1460-1460
Open Access | Times Cited: 1
Development and validation of a novel prognosis prediction model for M2-type macrophage of Clear cell carcinoma of kidney
Rui Sun, Jingdi Zhang
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top